Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AVATARE: NETosis Markers to Predict Thrombosis in MPN
NCT07119970Recruiting
- Sponsor
- Centre Hospitalier Universitaire de Bordeaux
- Start
- Dec 2025
- Primary completion
- Dec 2028
- Countries
- 1
01
Overview
Open-label trial (2 arms), sponsored by Centre Hospitalier Universitaire de Bordeaux. Primary endpoint: Serum calprotectin concentration at 0 months. Started Dec 2025; status: recruiting.
Beyond the preview
Go deeper on NCT07119970.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07119970.